{"id":4562,"date":"2023-07-28T12:50:02","date_gmt":"2023-07-28T12:50:02","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=4562"},"modified":"2023-07-28T12:54:14","modified_gmt":"2023-07-28T12:54:14","slug":"west-african-journal-of-pharmacy-2017-28-2-1-15","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2017-28-2-1-15\/","title":{"rendered":"West African Journal of Pharmacy (2017) 28 (2) 1-15"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

A review on drug quality surveillance in West Africa<\/b><\/p>

\u00a0<\/b><\/p>

Olajire A. Adegoke<\/p>

\u00a0<\/p>

Department of Pharmaceutical Chemistry<\/p>

Faculty of Pharmacy<\/p>

University of Ibadan, Nigeria<\/p>

Corresponding author: Olajire A. Adegoke<\/p>

Emails: jireade@yahoo.com Phone: +234 8036381625<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Background:<\/b> Comprehensive and concerted drug quality surveillance has been recognised as a panacea\u00a0towards ensuring that safe and effective drugs are in circulation.<\/span><\/p>

Objectives:<\/b> This review chronicles the efforts at ensuring good quality drugs within the West African sub-region. It also discusses the efforts of International donor agencies and National Drug Regulatory Agencies at\u00a0<\/span>combating the menace of substandard, spurious, falsely-labeled, falsified and counterfeit (SSFFC) medicines.<\/span><\/p>

Methods:<\/b> Literature searches were conducted on all reports detailing efforts within the various countries in\u00a0the sub-region. The expectations of various donor agencies and international organizations were reviewed\u00a0<\/span>from available reports. Efforts by the various National Agencies were also studied using information on their\u00a0<\/span>websites. Based on the available records, the recurring challenges were identified and solutions proffered.<\/span><\/p>

Results:<\/b> Several publications in scientific journals were found addressing the quality of circulating drugs within\u00a0West Africa. The reports spanned close to fifteen years. Majority of the reports on antibacterial agents focused\u00a0<\/span>more on antimicrobial resistance rather than on the quality of the agents. The efforts of the donors are\u00a0<\/span>commendable as they have been providing avenues in terms of technical training and provision of reference\u00a0<\/span>standards. Several challenges against effective drug quality are still prevalent in the sub-region.<\/span><\/p>

Conclusion:<\/b> It is imperative to note that the battle against circulation of SSFFCs is far from being won. Every\u00a0stakeholder in the drug distribution chain must arise to the responsibilities of eliminating them.<\/span><\/p>

Keywords:<\/b> Drug quality, Surveillance, West Africa, Counterfeit medicines, Challenges<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tDownload <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

A review on drug quality surveillance in West Africa \u00a0 Olajire A. Adegoke \u00a0 Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Ibadan, Nigeria Corresponding author: Olajire A. Adegoke Emails: jireade@yahoo.com Phone: +234 8036381625 ABSTRACT Background: Comprehensive and concerted drug quality surveillance has been recognised as a panacea\u00a0towards ensuring that safe and effective drugs […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[233],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4562"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=4562"}],"version-history":[{"count":4,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4562\/revisions"}],"predecessor-version":[{"id":4568,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4562\/revisions\/4568"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=4562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=4562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=4562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}